Abzena PLC (LON:ABZA)‘s stock had its “buy” rating reaffirmed by FinnCap in a report issued on Friday.

Separately, N+1 Singer reiterated a “corporate” rating on shares of Abzena PLC in a research note on Friday, October 21st.

Abzena PLC (LON:ABZA) opened at 32.50 on Friday. The stock’s market cap is GBX 44.25 million. The firm’s 50-day moving average is GBX 38.77 and its 200-day moving average is GBX 42.53. Abzena PLC has a 12 month low of GBX 31.00 and a 12 month high of GBX 65.00.

About Abzena PLC

Abzena plc is a life sciences company providing services and technologies. The Company is engaged in the provision of services and technology licenses. The Company consists of PolyTherics and Antitope, which have established a suite of services and technologies that are designed to improve the chances of development of antibodies and proteins with therapeutic benefits.

Receive News & Stock Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related stocks with our FREE daily email newsletter.